Dr. Vladimir (Zev) Zelenko
Total 39 Posts
Dr. Vladimir Zelenko is a Family Medicine Doctor in Monroe, NY. The 46-year-old native of Ukraine, he has been working as a doctor in the USA for the past 16 years.
Metamorphosis by Dr. Vladimir Zelenko: Chapters 1 and 2
This book describes how divine providence has guided and helped him overcome very difficult personal challenges including divorce and cancer. Today, we are publishing the first and the second chapters of the book.
Prehospital Management of COVID-19 Zelenko Protocol
Treatment Plan for Patients with symptoms of Covid-19.
Metamorphosis by Dr. Vladimir Zelenko: A Deeply Personal Journey of Spiritual Self-Discovery
This book describes how divine providence has guided and helped him overcome very difficult personal challenges including divorce and cancer.
Egy Frissen Kiadott TanulmáNY Megállapította, Hogy COVID-19 Járóbetegek Cink, Hidroxiklorokin éS Azitromicin KombináCIójával Történő KezeléSE Kevesebb Kórházi Felvétellel éS Halálos Végkimenetellel Járt.
A tanulmány nagyon alacsony, 0,71% -os halálozási arányról számolt be a kezelt betegekben, akiknél a COVID-19 pozitív esete volt.
Doctors From Harvard and Yale Medical Schools Support Dr. Zelenko's Treatment Method (The Zelenko Protocol)
A Yale faculty epidemiologist and a practicing MD formerly of the Harvard and MIT medical facilities join to support Dr. Zekenko’s scientifically published report on his groundbreaking medical practice protocol of successfully using HCQ to treat early-stage COVID19-infected patients.
އަލަށް ޝާ ިއޢުކޮށް ަފއި ާވ ތަހުލީލަކުން ދައްކާ ޮގތު ަގއި ޮކ ިވ ްޑ-19 ބަލި ެޖ ިހފަ ިއ ާވ މީ ުހންނަށް ޒިންކު، ހަ ިއޑްރޮކްސިކް ޮލރޮކީން އަ ިދ އެޒިތްރޮ ަމ ިއސިން ދީ ެގން ަފރު ާވ ުކ ުރމުން ހޮސްޕިޓަ ުލ ަގއި އެނދުމަތިކު ަރންޖެހޭ ައ ަދދު ދަ ްއ ޭވ
ފަރުވާދިނުމުން މަރުވާ މީހުންގެ އަދަދަކީ %0.71 ހާ ދަށް އަދަދެކެވެ.
Νέα έρευνα σε εξωτερικούς ασθενείς αποκαλύπτει ότι ο συνδυασμός Ψευδάργυρου, Υδροξυχλωροκινης, και αζιθρομυκίνης σχετίζεται με μειωμένες νοσηλείες και θανάτους σε ασθενείς με COVID-19
Η μελέτη αναφέρει ένα πολύ χαμηλό ποσοστό θνησιμότητας 0,71% σε ασθενείς που έλαβαν θεραπεία με επιβεβαιωμένα θετικά κρούσματα COVID-19.
